April 14, 2015

Actavis and Medicines360, a nonprofit women’s health pharmaceutical company, on Monday announced that Liletta (levonorgestrel-releasing intrauterine system) in 52 mg is now available in the United States.

April 14, 2015

Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.

April 13, 2015

WebMD is set to release a robust medication reminder function specifically designed for its Apple Watch app. 

April 10, 2015

Surescripts has expanded its nationwide health information network to include PointClickCare, a cloud-based software platform for the senior care market.
 

April 10, 2015

Tennessee on Wednesday became the eighth state to restrict DXM sales. 

April 8, 2015

Hi-Tech Pharmaceuticals on Tuesday contended the findings in a Drug Testing and Analysis study. 

April 8, 2015

Strong same-store sales help lift Rite Aid annual revenue 3.9% to $26.5 billion. 

April 7, 2015

The Canadian Generic Pharmaceutical Association on Tuesday established a new Biosimilars Board. 

 

 

April 7, 2015

Harvard researcher on Tuesday reported that BMPEA, an amphetamine isomer, was found in supplements containing the ingredient Acacia rigidula. 

April 7, 2015

The disparity between reimbursement rates and generic drug costs caused by a lag in payment is forcing many community pharmacies to operate at a negative margin.

April 6, 2015

A University of Southern California pilot currently underway at several California clinics is illustrating the important role that clinical pharmacists can play in team-based medical care.

April 2, 2015

Rite Aid's March results spurred a 3% lift in its share price Thursday morning. 

April 2, 2015

Sam's Club on Thursday sweetened the pot for its Plus and Business Plus members with an offering of five generic prescriptions without charge in most states. 

April 2, 2015

Alere's i Strep A test received marketing clearance from the Food and Drug Administration on Thursday. 

April 1, 2015

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

April 1, 2015

Teva said it expects the product to be available to patients during second-quarter 2015.

March 31, 2015

The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.

March 31, 2015

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

March 27, 2015

The Food and Drug Adminisration on Friday revisited the issue of supplemental applications proposing labeling changes for approved drugs and biologic products. 

March 26, 2015

Kentucky last week became the seventh state to restrict DXM sales to adults. 

March 26, 2015

The Council for Responsible Nutrition on Thursday called on its members not to market powdered pure caffeine to consumers in support of FDA efforts.

March 24, 2015

Actavis last week announced that its acquisition of Allergan has been completed in a transaction valued at $70.5 billion, a deal that creates one of the world’s top 10 pharmaceutical companies by sales revenue, according to the company.

March 23, 2015

The Food and Drug Administration last week warned consumers against using homeoapthic asthma remedies. 

March 23, 2015

Acura Pharmaceutical's Nexafed extended release demonstrated bioequivalence to Sudafed 12-hour tablets.